Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5691226 | 1.00 | CA2 (0.61) | CA2CA9CA12CA1CA7 | |
| SCHEMBL9581449 | 0.95 | CA12 (0.56) | CA2CA9CA12CA1CA7 | |
| SCHEMBL12544707 | 0.95 | CA12 (0.56) | CA2CA9CA12CA1CA7 | |
| SCHEMBL235800 | 0.90 | CA2 (0.73) | CA2CA9CA12CA1CA7 | |
| Hydrochloric Acid SCHEMBL28242785 | 0.88 | CA2 (0.70) | CA2CA9CA12CA1CA7 | |
| SCHEMBL21784421 | 0.87 | KMT2A (0.61) | CA2CA9CA12CA1CA7 | |
| SCHEMBL5863155 | 0.85 | CA2 (0.66) | CA2CA9CA12CA1CA7 | |
| SCHEMBL16351851 | 0.85 | CA2 (0.66) | CA2CA9CA12CA1CA7 | |
| SCHEMBL87450 | 0.84 | CA1 (0.83) | CA2CA9CA12CA1CA7 | |
| SCHEMBL22920969 | 0.84 | ALDH1A1 (0.57) | CA2CA9CA12CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9331284-B2 | Polymer compound and light-emitting device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9269905-B2 | Polymer compound having carbon cluster structure and organic device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20130270545-A1 | POLYMER COMPOUND HAVING CARBON CLUSTER STRUCTURE AND ORGANIC DEVICE USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2012-12-27 | — | — | US | disclosed |
| US-20110187266-A1 | POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110127512-A1 | COPOLYMER AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CCNA1, CCNB1, CCNL2 | CA2 3443/4885CA9 3140/4885CA12 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.